Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.07.21.739721

Active histone modifications fine-tune DNA N-6 methyladenine deposition and maintain transcriptional stability

Abstract

Epigenetic mechanisms provide sophisticated regulatory layers that modulate gene expression across diverse organisms, yet their organization and crosstalk remain poorly understood in non-dikarya fungi (NDF). Here, we characterize the genome-wide landscape of chromatin organization in the fungus Rhizopus microsporus, revealing a compartmentalized architecture where active histone modifications (H3K4me1, H3K4me3, H3K27ac) define transcriptionally active euchromatin distinct from H3K9me3-marked constitutive heterochromatin. Through comprehensive ChIP-seq analysis, we demonstrate that these modifications exhibit distinct distribution patterns over gene bodies and co-localize with 6-methyladenine (6mA) clusters (MACs), an essential epigenetic mark that is associated with transcription in this fungus. We identified functional specialization among H3K4 methyltransferase Set1 paralogs, where Set1a primarily deposits H3K4me3 and Set1b deposits H3K4me1. In contrast, both Gcn5 paralogs function redundantly in H3K27 acetylation. Knockout analysis reveals that these enzymes are critical for sporulation, stress resistance, and pathogenesis. Importantly, we uncover an epigenetic crosstalk in which active histone modifications restrict off-target 6mA deposition, regulate methylation cluster stability, and buffer transcriptional variation. Our findings reveal conserved principles of epigenetic crosstalk between active histone modifications and the essential DNA modification 6mA that may represent a fundamental mechanism of chromatin regulation in eukaryotes. SIGNIFICANCEEpigenetic mechanisms regulate gene activity without altering the DNA sequence, yet how different epigenetic marks interact remains poorly understood. Here, we characterize the genome-wide distribution of active histone modifications and DNA N6-methyladenine (6mA) in the fungus Rhizopus microsporus, revealing that they define distinct active and inactive chromatin domains. While 6mA plays a central role in transcriptional regulation, active histone modifications direct its accurate deposition and maintenance, thereby reducing transcriptional variability. These findings uncover conserved crosstalk between histone modifications and 6mA that may represent a fundamental principle of chromatin regulation across eukaryotes.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Lax, C., Osorio-Concepcion, M., Nicolas-Munoz, N., Tahiri, G., Mondo, S. J., Ng, V., Navarro, E., Grigoriev, I. V., Meza-Carmen, V., Nicolas, F. E., Garre, V.. 2026-07-21. Active histone modifications fine-tune DNA N-6 methyladenine deposition and maintain transcriptional stability. https://doi.org/10.64898/2026.07.21.739721

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Mechanism-selective deep mutational scanning distinguishes ERCC2 disease phenotypes

Pathogenic ERCC2 variants cause xeroderma pigmentosum (XP), trichothiodystrophy (TTD) or both, yet variant effect scores are usually interpreted only as measures of pathogenicity rather than of which disease mechanism is disrupted. XPD, the ERCC2-encoded TFIIH subunit, functions in both nucleotide excision repair and transcription. Using yeast complementation deep mutational scanning, we measured the effects of nearly all XPD amino acid substitutions. The assay was mechanism-selective: it preferentially reported transcription-associated function, with pronounced intolerance at the p44 interface, whereas many substitutions affecting DNA binding and helicase activity retained near-wild-type fitness. Accordingly, TTD variants had much lower fitness than XP variants. Computational predictors discriminated pathogenic from benign variants similarly across phenotypes, but the DMS distinguished XP from TTD variants better than all 73 predictors tested. Phenotype-specific ACMG/AMP calibration provided evidence in both directions for TTD but mainly pathogenic evidence for XP. Thus, the selectivity of functional assays, often viewed as a limitation, can reveal disease mechanisms and support phenotype-aware variant interpretation.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗